In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomes

This publication has 19 references indexed in Scilit:

• KR-32570, a novel Na+/H+ exchanger-1 inhibitor, attenuates hypoxia-induced cell death through inhibition of intracellular Ca2+ overload and mitochondrial death pathway in H9c2 cells
  European Journal of Pharmacology, 2005
• Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion
  European Journal of Pharmacology, 2005
• High‐throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
  Rapid Communications in Mass Spectrometry, 2005
• Identification of Rat Urinary and Fecal Metabolites of a New Herbicide, Pyribenzoxim
  Journal of Agricultural and Food Chemistry, 2005
• (5-Arylfuran-2-ylcarbonyl)guanidines as Cardioprotectives through the Inhibition of Na⁺/H⁺ Exchanger Isoform-1
  Journal of Medicinal Chemistry, 2005
• Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8
  The Journal of Clinical Pharmacology, 2005
• Metabolism of a new neuroprotective agent for ischemia-rep-erfusion damage, KR-31543 in the rats using liquid chroma-tography/electrospray mass spectrometry
  Archives of Pharmacal Research, 2002
• Discussion
  Biochemical Pharmacology, 1999
• Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9
  Xenobiotica, 1995
• Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.
  British Journal of Clinical Pharmacology, 1990